SCHEMBL26293103

SCHEMBL26293103

COC(CO)CC(F)n1cc(F)c(N)nc1=O

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALB P02768 1/20 0.35
EP300 Q09472 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19049965 0.76 TYMP (0.30) EP300
SCHEMBL17976548 0.72 ALB (0.34) ALBEP300
SCHEMBL12228265 0.71 ALB (0.36) ALBEP300
SCHEMBL26270693 0.71 ALB (0.34) ALBEP300
SCHEMBL23171084 0.71 ALB (0.32) ALBEP300
SCHEMBL19242529 0.70 ALB (0.35) ALBEP300
SCHEMBL10137844 0.70 ADORA2A (0.38) ALBEP300
SCHEMBL26282235 0.70 ALB (0.33) ALBEP300
SCHEMBL19049963 0.69 FGFR1 (0.44) ALB
SCHEMBL20879430 0.69 ALB (0.33) ALBEP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023178133-A9 COMPOUNDS AND METHODS FOR TREATING DISEASE ROME THERAPEUTICS, INC. (US) 2023-10-26 WO disclosed
WO-2023178133-A1 COMPOUNDS AND METHODS FOR TREATING DISEASE ROME THERAPEUTICS, INC. (US) 2023-09-21 WO disclosed